Indian generic drugmakers such as Sun Pharma, Cipla, Dr Reddy's and Lupin are beginning to develop their own versions of Novo Nordisk's blockbuster weight-loss drug Wegovy. Some analysts predict the weight-loss drug market could reach $100 billion annually by 2030 as obesity rates rise globally. Novo Nordisk has been unable...
Lilly to Launch Diabetes Drug Mounjaro in India
Eli Lilly is planning to launch its blockbuster type 2 diabetes drug Mounjaro (tirzepatide) in India as early as next year, according to e Reuters. Mounjaro is currently under review by Indian health authorities, with Lilly having submitted data from its global clinical trials that included Indian patients. Tirzepatide, the...